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Apoptosis in the Hair Follicle
Natalia V. Botchkareva1, Gurpreet Ahluwalia1 and Douglas Shander1
Apoptosis plays an important role in many physiological processes, ranging from morphogenetic events to adult 
tissue homeostasis, and defects in its regulation contribute to many disorders. Here we review molecular mecha-
nisms of apoptosis in the hair follicle (HF), whose cyclical growth pattern is repeatedly interrupted by apop-
tosis-driven involution (catagen). We review the common mechanisms underlying apoptosis in the HF during 
catagen, as well as differences in the regulation of apoptosis between distinct HF cell populations. An overview is 
provided on the expression and function of molecules involved in the control of various phases of the apoptotic 
process during catagen.
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Apoptosis is a process of eliminating 
cells that have fulfilled their biological 
function during development and tissue 
homeostasis in multicellular organisms. 
During the last decade, substantial prog-
ress was achieved in the delineation of 
molecular mechanisms involved in the 
realization of apoptosis. As an energy-
demanding process, apoptosis is initi-
ated by a variety of stimuli, including a 
withdrawal of growth factors, loss of cell 
adhesion, stimulation of proapoptotic 
receptors, or DNA damage (reviewed 
by Afford and Randhawa, 2000).
The hair follicle (HF) is a cutaneous 
organ that shows cyclic activity in post-
natal life and transits through periods 
of active hair growth (anagen), apop-
tosis-driven involution (catagen), hair 
shedding (exogen), and relative resting 
(telogen) (Paus and Cotsarelis, 1999; 
Cotsarelis and Millar, 2001; Stenn and 
Paus, 2001). During HF growth and 
hair production, the activity of factors 
promoting the proliferation, differen-
tiation, and survival predominates, 
whereas HF regression is characterized 
by the activation of a variety of signal-
ing pathways that induce apoptosis in 
HF cells (Lindner et al., 1997; Soma et 
al., 1998; Stenn and Paus, 2001). This 
review focuses on the molecular mech-
anisms of apoptosis in the HF during its 
physiological involution; mechanisms 
of apoptosis underlying the distinct hair 
loss conditions have been reviewed 
elsewhere (Botchkarev, 2003; Cotsarelis 
and Millar, 2001; Hendrix et al., 2005).
Apoptosis As a Multi-Step Program of 
Cell Death
Morphologically, apoptosis is charac-
terized by cell shrinkage, membrane 
blebbing, nuclear condensation, and 
cellular fragmentation, followed by 
the formation and the phagocytosis of 
apoptotic bodies. The process of apop-
tosis can be divided into four stages: 
initiation, intracellular response, 
cell fragmentation, and phagocytosis 
(reviewed by Afford and Randhawa, 
2000).
Stages of Initiation and Intracellular 
Response of Apoptosis
The extrinsic apoptotic pathway is acti-
vated by binding of specific ligands 
to the members of the ‘death domain’ 
family of membrane receptors (Curtin 
and Cotter, 2003) (Figure 1). All death 
receptors have an extracellular cys-
teine-rich domain that is required for 
ligand binding and an intracellular 
domain essential for signal transduction 
(Peter and Krammer, 2003).
Signaling via death receptors results 
in the recruitment of several intracel-
lular adapter molecules specific for 
each apoptotic receptor (Fas-associ-
ated death domain protein, tumor 
necrosis factor (TNF) receptor 1–asso-
ciated death domain, receptor-inter-
acting protein 1, and so on; see Figure 
1), all of which contain the death 
effector domains required for the 
interaction with similar domains of pro-
caspase-8 and procaspase-10 (Curtin 
and Cotter, 2003; Roux and Barker, 
2002). Activation of caspase-8 and cas-
pase-10 results in their recruitment into 
the death-inducing signaling complex, 
followed by activation of caspase-3 
along the common apoptotic pathway 
(Peter and Krammer, 2003). Caspase-8 
may also activate the cytoplasmic pro-
tein Bid, which, after its translocation 
to the mitochondria, induces release of 
cytochrome c, thus linking the extrin-
sic and intrinsic apoptotic pathways 
(Schultz and Harrington, 2003).
The intrinsic pathway of apoptosis 
is activated by a variety of intracellular 
events that lead to the release of cyto-
chrome c from the mitochondria. This 
process is controlled by proteins of the 
Bcl-2 family, which are divided into 
two groups: inhibitors of apoptosis (for 
example, Bcl-2, Bcl-xL, and Mcl-1) and 
promoters of apoptosis (for example, 
Bax, Bak, Bok, Bcl-xS, Bik, Bim, Bad, 
and Bid) (van Gurp et al., 2003). Bim, 
Bad, and Bid may act as sensors for 
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cellular integrity and the growth factor 
supply. Bim serves as a sensor of cyto-
skeleton integrity, and its proapoptotic 
activity is regulated by interaction with 
the dynein motor complex (Puthalakath 
et al., 1999). Bad operates as a sensor 
for growth factor withdrawal, as depriva-
tion of survival growth factors induces 
Bad dephosphorylation, which results in 
apoptosis (Chiang et al., 2001). The cyto-
plasmic protein Bid may be cleaved by 
caspase-8, granzyme B, and cathepsin 
into a truncated isoform (tBid), which, 
after translocation to the mitochondria, 
promotes cytochrome c release and 
apoptosis (van Gurp et al., 2003).
After its release into the cytoplasm, 
cytochrome c recruits the caspase adapt-
er molecule Apaf-1 and the apoptosis ini-
tiator enzyme procaspase-9, which toge-
ther form a holoenzyme complex called 
an apoptosome (van Gurp et al., 2003). 
Apoptosomes promote the formation of 
the active form of caspase-3 along the 
common pathway of apoptosis (Figure 
1). Caspase-3 activation may be inhibited 
by members of the inhibitor of apoptosis 
protein (IAP) family, which are located in 
the cytosol and prevent the activation of 
procaspases. However, during apoptosis 
the inhibitory activity of IAPs is neutral-
ized by Smac/DIABLO protein, which is 
released from the mitochondria and is 
capable of sequestering IAPs (van Gurp 
et al., 2003; Riedl and Shi, 2004).
Stage of Cell Fragmentation and 
Phagocytosis of Apoptotic Cells
Both extrinsic and intrinsic apoptotic 
pathways result in the activation of cas-
pase-3, which is believed to be the key 
proteolytic enzyme capable of cleaving 
a large variety of intracellular substrates. 
These include structural and signaling 
proteins, transcription factors, and regu-
lators of DNA repair and RNA metabo-
lism (Shi, 2002). In addition, caspase-3 
cleaves caspase-activated deoxyri-
bonuclease, which translates into the 
nucleus and initiates DNA cleavage 
(van Gurp et al., 2003). These processes 
result in the appearance of the degraded 
chromatin fragments, lysosomes, mito-
chondria, and other degenerated cell 
organelles covered by cell membrane, 
which are morphologically distinguish-
able as apoptotic bodies (Afford and 
Randhawa, 2000; Shi, 2002).
During the final steps of apoptosis, 
cellular, and nuclear fragmentation is 
also accompanied by changes in the 
cell membrane and by the translocation 
of phosphatidylserine from the inner to 
the outer portion of the cell membrane, 
leading to its recognition by neighbor-
ing cells, macrophages, or dendritic 
cells and then to its phagocytosis 
(Fadok, 1999; Afford and Randhawa, 
2000; Schultz and Harrington, 2003). 
CD14, CD36, CD68, the class A sca-
venger receptors and the vitronectin 
receptor expressed by macrophages 
are all capable of interaction with sev-
eral molecular determinants expressed 
on apoptotic cells, including anionic 
phospholipids, phosphatidylserine, and 
ICAM-3 (Afford and Randhawa, 2000). 
In addition, serum proteins such as 
β2-glycoprotein and the complement 
component C1q can bind to apoptotic 
cells and enhance their uptake by mac-
rophages (Kagan et al., 2003).
Physiological Hair Follicle Regression 
(Catagen) As a Model of Apoptosis-Driven 
and Fully Reversible Organ Involution
Although catagen is often thought of 
as a regressive event, it is an exqui-
sitely orchestrated energy-requir-
ing remodeling process, whose pro-
gression assures renewal of further 
generation of HFs. Catagen was first 
characterized in detail by Kligman 
and by Straile et al. (Kligman, 1959; 
Straile et al., 1961). It lasts about 
2–3 weeks in humans and 3 days in 
mice (Kligman, 1959; Parakkal, 1970; 
Straile et al., 1961). Morphologically 
and functionally, catagen is divided 
into eight substages, each character-
ized by distinct patterns of apoptosis 
(Müller-Röver et al., 2001) (Figure 2a).
During the murine hair cycle, apop-
totic cells visualized by TUNEL staining 
first appear in the melanogenic area of 
the late-anagen HF (Tobin et al., 1998). 
In early-catagen HFs, apoptotic cells are 
seen in the HF matrix; later, TUNEL+ 
cells are seen in the outer and inner 
root sheaths (mid- and late catagen) 
and are then abundant in the epithe-
lial strand (late catagen) (Lindner et al., 
1997; Matsuo et al., 1998). In advanced 
catagen stages, TUNEL+ cells are also 
present in the club hair and in the bulge 
(Lindner et al., 1997; Ito et al., 2004). 
However, apoptotic cells are never seen 
in the dermal papilla of catagen HFs 
in humans and mice under physiologi-
cal conditions (Lindner et al., 1997; 
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Figure 1. Molecular mechanisms of the distinct phases of the apoptotic process. Scheme demonstrates 
integration of the molecules involved in the control of various phases of apoptosis (initiation, 
intracellular response, cell fragmentation, phagocytosis). AIF, apoptosis-inducing factor; Akt, protein 
kinase B; Apaf-1, apoptotic peptidase activating factor 1 Cyt c, cytochrome c; Endo G, endonuclease G; 
Jnk, c-Jun N-terminal kinase.
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Matsuo et al., 1998; Soma et al., 1998). 
Therefore, the spatio-temporal distribu-
tion of TUNEL+ cells in the HF during 
catagen may be considered as a ‘wave’ 
starting from the melanogenic area (late 
anagen), propagating to the hair matrix 
(early catagen) and then to the proxi-
mal/central outer and inner root sheaths 
and hair shaft (mid- and late catagen).
Distinct cell populations in the HF 
possess differential susceptibility to 
apoptosis. The most susceptible to 
apoptosis are the majority of the follic-
ular epithelial cells and melanocytes, 
whereas dermal papilla fibroblasts, 
and some of the keratinocytes (KCs) 
and melanocytes selected for survival, 
are resistant to apoptosis (Lindner et 
al., 1997; Seiberg et al., 1995; Tobin 
et al., 1998). Apoptotic cells in the HF 
are phagocytosed by macrophages and 
by neighboring epithelial cells, which 
fill the space left by apoptotic cells 
(the “apoptotic force” hypothesis intro-
duced by K. Stenn (Stenn and Paus, 
2001)). Loss of cell adhesion between 
KCs may also be considered a catagen-
promoting factor, as ICAM-1-deficient 
mice show significant catagen accel-
eration (Müller-Röver et al., 2000a). 
This loss of cell adhesion leads to a 
progressive reduction in the size of the 
proximal hair bulb (early and mid-
catagen) and to rapid shortening of the 
outer and inner root sheaths and hair 
shaft (mid- and late catagen).
Catagen is also characterized by the 
formation of a specialized structure in 
the HF, the club hair, that connects the 
proximal part of the hair shaft with sur-
rounding HF epithelium and anchors 
hair in the telogen HF (Parakkal, 1970; 
Pinkus et al., 1981). During catagen, 
the dermal papilla is transformed into a 
cluster of quiescent cells closely adja-
cent to the regressing HF epithelium, 
which moves from the subcutis to the 
dermis/subcutis border to contact the 
distal portion of the HF epithelium, 
including the secondary hair germ and 
bulge. In the hairless gene mutation, the 
disintegration of the dermal papilla and 
the HF epithelium during catagen leads 
to the loss of the capacity of the HF to 
reenter anagen (Ahmad et al., 1998; 
Panteleyev et al., 1999).
Molecular Mechanisms of Apoptosis in 
the Hair Follicle During Catagen
The physiological involution of the HF 
may be triggered by a variety of stimu-
li, including signaling via death recep-
tors, and by the withdrawal of growth 
factors that maintain cell proliferation 
and differentiation in the anagen HF. 
Accumulating evidence suggests that 
apoptosis in every distinct HF compart-
ment is regulated differently (Figure 3).
Apoptosis in the follicular melano-
cytes. Recent data based on monitoring 
of the fate of melanocytes during cata-
gen in Trp2-LacZ transgenic mice sug-
gest that distinct subsets of melanocytes 
(located in the bulge, in the outer root 
sheath, and above the dermal papilla; 
Botchkareva et al., 2001) show differ-
ent sensitivities to apoptosis (Sharov et 
al., 2005). Specifically, apoptosis occurs 
only in differentiated melanocytes that 
are located above the dermal papilla 
and express the Fas receptor, whereas 
the other subpopulations, which express 
the c-Kit receptor and Bcl-2, most likely 
survive catagen (Sharov et al., 2005). 
Thus, Fas signaling may contribute to 
melanocyte apoptosis during catagen, 
similar to that seen after exposure of HFs 
to chemotherapy (Sharov et al., 2003).
Stem cell factor/c-Kit and Bcl-2 are 
two important candidate molecules 
that may promote melanocyte survival 
during catagen. Constitutive stem cell 
factor/c-Kit ablation or administration 
of c-Kit-neutralizing antibody leads to 
apoptosis and the disappearance of 
a f
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Figure 2. Catagen development in the human HF. (a) Alterations in HF morphology at distinct stages of anagen-catagen-telogen transition. During anagen-
catagen transition (Catagen II), the size of the hair matrix (arrow) and dermal papilla (arrowhead) is reduced. During the advanced catagen stages (Catagen 
V), the dermal papilla is condensed and transformed into a cluster of quiescent cells (arrowhead), and the epithelial strand (arrow) and club hair (asterisk) 
are formed. In telogen (right), HF length is substantially reduced, and the HF contains two specialized structures, the secondary hair germ (arrowhead) and 
club hair (asterisk). (b), (c) Bax. In anagen, weak Bax expression is seen in the central inner root sheath (b, arrow). In catagen, Bax expression appears in the 
regressing hair matrix, the inner root sheath, and the connective tissue sheath (c, large arrowhead, arrow, and small arrowhead, respectively). (d), (e) Caspase-
8. In anagen, caspase-8 expression is restricted to the perifollicular connective tissue sheath (d, arrows). In early catagen, in addition to the connective tissue 
sheath, caspase-8 appears in central and distal parts of the outer root sheath (e, arrow and arrowhead, respectively). (f) TUNEL (green) plus Ki67 (red). Laser 
treatment promotes catagen development accompanied by massive apoptosis in the HF: TUNEL+ cells are located in the regressing epithelium (arrow), club 
hair (arrowhead), and dermal papilla (asterisk).
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melanoblasts in mouse embryos (Ito et 
al., 1999). Bcl-2 specifically protects the 
melanocyte stem cells in the HF from 
apoptosis, and Bcl-2 deficiency results 
in their apoptotic elimination and pre-
mature hair graying (Veis et al., 1993; 
Nishimura et al., 2005). However, 
cross-talk between the stem cell fac-
tor/c-Kit pathway and mitochondrial 
antiapoptotic proteins in the control of 
melanocyte survival has yet to be fur-
ther clarified.
Apoptosis in the hair matrix kerati-
nocytes. Data obtained from murine 
and human HFs suggest that apop-
tosis in hair matrix KCs is controlled 
by extrinsic and intrinsic pathways. 
The p55 subunit of the TNF recep-
tor may be involved in the extrinsic 
apoptotic pathway, as it is expressed 
in the hair matrix during catagen, and 
TNF-α treatment results in an increase 
of TUNEL+ cells in the hair matrix 
(Lindner et al., 1997; Ruckert et al., 
2000). Also, TNF-α promotes anagen-
catagen transition in human HFs in 
vitro (Hoffmann et al., 1996).
Apoptosis in hair matrix KCs is also 
accompanied by the activation of 
intrinsic apoptotic pathways. During 
catagen in mice, the Bcl-2/Bax ratio in 
hair matrix KCs is markedly decreased, 
compared with anagen levels (Figure 
2b and c) (Lindner et al., 1997). The 
Survivin protein, which belongs to the 
IAP family, is prominently expressed in 
the proliferating cells of the hair matrix, 
whereas its expression is progressively 
decreased during catagen (Botchkareva 
et al., 2005).
The p53 transcription factor also 
plays an important role in regulation 
of apoptosis in hair matrix KCs: cata-
gen HFs of p53-null mice contain 
fewer apoptotic cells and show sig-
nificantly retarded catagen progres-
sion, compared with catagen HFs of 
wild-type mice (Botchkarev et al., 
2001). p53 may promote the intrinsic 
apoptotic pathway in hair matrix by 
regulating the expression of the mito-
chondrial protein Bax, as such expres-
sion is increased in the hair matrix 
during catagen (Lindner et al., 1997; 
Botchkarev et al., 2001).
The hairless transcription factor also 
serves as an important regulator of 
apoptosis in the HF: in hairless mice, 
apoptosis in hair matrix KCs is strong-
ly increased, leading to a premature 
switch from anagen to catagen and 
eventually resulting in disintegration 
of the dermal papilla from the follicu-
lar epithelium and permanent hair loss 
(Ahmad et al., 1998; Panteleyev et al., 
1999; Panteleyev et al., 2000). It was 
recently shown that hairless protein 
serves as a transcriptional co-repressor 
for the vitamin D receptor (Hsieh et al., 
2003; Potter et al., 2001); this suggests 
that interactions between hairless pro-
tein and vitamin D receptor might con-
tribute to apoptosis in HF KCs.
Interestingly, apoptosis in the hair 
matrix is strongly increased in keratin 
17 knockout mice (McGowan et al., 
2002); this provides the first evidence 
that ablation of a structural protein 
may cause apoptosis in the HF KCs. It 
remains to be determined, however, 
whether keratin 17 deletion results in 
direct activation of the intrinsic apoptot-
ic pathway, employing Bim as a sensor 
of cytoskeleton integrity (Puthalakath 
et al., 1999), or whether other mecha-
nisms are involved in this process.
Effector mechanisms of apoptosis in 
the murine and human HFs are most 
likely mediated by caspase-1, caspase-
3, caspase-4, and caspase-7, which are 
highly expressed in the hair matrix dur-
ing catagen and may be involved in the 
cell fragmentation process (Lindner et 
al., 1997; Soma et al., 1998).
Apoptosis in the outer root sheath. 
Before or during catagen, outer root 
sheath KCs produce several important 
catagen-promoting secreted molecules: 
fibroblast growth factor-5 short isoform, 
neurotrophins, transforming growth 
factor-β1/2 (TGF-β1/2), IGF bind-
ing protein 3, and thrombospondin-1 
(Botchkarev et al., 2001; Botchkarev 
et al., 2004; Suzuki et al., 1998; Yano 
et al., 2003). Overexpression of one of 
the antiapoptotic mitochondrial pro-
teins Bcl-2 and Bcl-xL in the outer root 
sheath KCs leads to premature termina-
tion of anagen and catagen accelera-
tion, whereas fibroblast growth factor-5 
deficiency rescues these effects (Pena et 
al., 1999; Müller-Röver et al., 2000b. 
This suggests that the elevated levels 
of Bcl-2 and Bcl-xL in the outer root 
sheath stimulate survival and/or activ-
ity of cells that promote HF anagen-
catagen transition.
Along with the secretion of cata-
gen stimulatory molecules, outer root 
sheath KCs express apoptotic death 
receptors such as Fas, p55 TNF recep-
tor, and p75 neurotrophin receptor, as 
well as TGFβ-1/2 receptors (Lindner 
et al., 1997; Paus et al., 1997; Foitzik 
et al., 2000). This suggests that outer 
root sheath cells are also the targets 
for active elimination during catagen. 
The central outer root sheath of human 
catagen HFs displays high expression 
of caspase-8 (Figure 2d and 2e), which 
links death receptor signaling with 
the activation of caspase-3 (Peter and 
Krammer, 2003). Outer root sheath KCs 
expressing p75NTR and TGF-β  recep-
tors become TUNEL+ during catagen 
(Botchkarev et al., 2000; Foitzik et al., 
2000). In contrast to corresponding 
wild-type mice, p75NTR and TGF-β1 
knockout mice display significant cata-
gen retardation associated with the 
decline of apoptotic cells in the regress-
ing outer root sheath (Botchkarev et al., 
2000; Foitzik et al., 2000). Thus, by 
stimulating apoptosis, neurotrophins 
and TGF-β1/2 may promote shortening 
of the outer root sheath in catagen HFs. 
These data are consistent with results 
that show potent catagen-promoting 
activities of neurotrophins and TGF-β2 
in human HFs (Soma et al., 2002; Tsuji 
et al., 2003; Peters et al., 2005).
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Figure 3. Molecular mechanisms of apoptosis 
control in the distinct HF compartments. Scheme 
demonstrates the expression pattern of anti- and 
proapoptotic molecules (shown in brown and 
black, respectively) in the HF. GDNF, glial cell 
line–derived neurotrophic factor.
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Apoptosis in the inner root sheath 
and the hair shaft. During catagen, 
inner root sheath KCs show strong 
upregulation of the Fas/apo receptor 
(Lindner et al., 1997), implicating its 
involvement in apoptosis. Proteolytic 
enzyme L-cathepsin and hairless may 
also contribute to apoptosis in the 
inner root sheath, as both L-cathepsin-
deficient and hairless-deficient mice 
show retarded inner root sheath short-
ening and decreased apoptosis during 
catagen (Panteleyev et al., 2000; Tobin 
et al., 2002). Antiapoptotic effects in 
the inner root sheath may be mediated 
by glial cell line–derived neurotrophic 
factor and neurturin; their correspond-
ing receptors, GFRα1 and GFRα2, are 
expressed in the inner root sheath dur-
ing catagen, and GFRα1- and GFRα2-
deficient mice show significant catagen 
acceleration, compared with wild-type 
controls (Botchkareva et al., 2000).
Less is known about the mechanisms 
that control apoptosis in hair shaft KCs. 
In catagen, hair shaft KCs do not express 
apoptotic receptors (Lindner et al., 
1997), although single TUNEL+ cells 
could be detected (Soma et al., 1998). 
During mid-catagen and late catagen, 
TUNEL+ cells become abundant in the 
proximal end of the hair shaft, that is, in 
the area of trichilemmal keratinization 
and club hair formation (Lindner et al., 
1997; Matsuo et al., 1998). However, as 
TUNEL staining is not always a marker 
of apoptotic cells (Magerl et al., 2001), 
it is difficult to conclude whether apop-
tosis plays a role in club hair formation.
Clearance of the apoptotic cells from 
the HF during catagen. Little is known 
about the mechanisms that control 
clearance of the apoptotic cells from 
the HF during catagen. As was shown 
in other models of biological regres-
sion (involution of the mammary gland 
or thymic epithelium), apoptotic cells 
are eliminated by macrophages or by 
neighboring epithelial cells (reviewed 
by Fadok, 1999). Dendritic cells that 
are present in human anagen HFs in 
distal HF epithelium and express C1q 
may be closely involved in the rec-
ognition and phagocytosis of apop-
totic cells (Christoph et al., 2000). 
Apoptotic cells may also be eliminated 
by macrophages that are located in 
the connective tissue sheath and that 
express CD68 (Christoph et al., 2000). 
Interestingly, the molecules that stimu-
late catagen development (interleukin 
1β, TNF-α, TGF-β1) are also known to 
significantly augment phagocytosis of 
apoptotic cells by macrophages (Ren 
and Savill, 1995). However, the precise 
mechanisms involved in recognition 
and elimination of apoptotic cells in 
catagen HFs remain unclear.
Hair follicle cell populations that 
survive catagen. Survival of distinct 
HF cell populations during catagen is 
essential for maintenance of HF regen-
eration in subsequent hair cycles. These 
cell populations include fibroblasts of 
the dermal papilla and connective tis-
sue sheath, KC and melanocyte stem 
cells and some of their daughter (tran-
sient amplifying) cells (Ito et al., 2004; 
Nishimura et al., 2005; Sharov et al., 
2005). Dermal papilla fibroblasts show 
potent resistance to apoptosis associ-
ated with high levels of Bcl-2 and lack 
of death receptors during the entire hair 
cycle in mice and humans (Lindner et 
al., 1997; Matsuo et al., 1998; Soma 
et al., 1998). However, they may be 
susceptible to apoptosis under certain 
experimental conditions (application 
of trypsin or staurosporine) or geneti-
cally altered conditions (hairless mice) 
(Ferraris et al., 1997; Seiberg et al., 
1997; Panteleyev et al., 1999). Although 
the majority of KC stem cells survive 
during catagen, some bulge cells under-
go apoptosis (Ito et al., 2004). However, 
the mechanisms and purpose of this 
process remain to be further clarified.
Perspectives: Modulation of Apoptosis in 
the Hair Follicle as a Tool for Correction 
of Hair Growth Abnormalities
Defects in the regulation of apoptosis 
contribute to many diseases, including 
hair growth disorders (hirsutism and 
various hair loss conditions; Paus and 
Cotsarelis, 1999). Recently, new drugs 
for modulating apoptosis (for example, 
TNF-α-inhibiting antibodies, Bcl-2/Bcl-
xL antisense oligonucleotides, synthetic 
p53, and caspase inhibitors) have been 
identified, and some of them have been 
successfully tested in clinical practice 
(Komarov et al., 1999; Reed, 2002; 
Kiechle and Zhang, 2002). It was dem-
onstrated that HFs in a number of hair 
loss conditions (androgenetic alopecia, 
chemotherapy-induced hair loss) show 
alterations in apoptosis (Sawaya et al., 
2002; Botchkarev et al., 2000). Perhaps 
apoptosis inhibitors can be used to 
reduce apoptosis activity in the HFs 
affected by distinct forms of alopecia. 
Pharmacological suppression of TGF-
β2 by plant extract promotes human 
HF growth in vitro and delays in vivo 
catagen development in mice  (Tsuji et 
al., 2003); this suggests that a suppres-
sor of TGF-β might also be effective in 
preventing male pattern baldness.
As an alternative to pharmacologi-
cal apoptosis manipulation, physi-
cal methods that are widely used for 
management of unwanted hair growth 
(laser- and light-induced hair removal) 
are also capable of inducing catagen 
and apoptosis in the HF (Figure 2f) 
(Shander et al., 1999). These methods 
are based on the selective absorption of 
light by the HF chromophores, includ-
ing melanocytes. It remains to be deter-
mined whether these methods may be 
combined with pharmacological apop-
tosis modulation for the correction of 
hair growth abnormalities. Progress in 
these areas of research will result in 
the development of novel strategies for 
therapeutic intervention in the deregu-
lated apoptotic process seen in the dis-
orders of hair growth.
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